Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case–control study of contralateral breast cancer risk in the WECARE Study
Main Authors: | Brooks, Jennifer D., Teraoka, Sharon N., Bernstein, Leslie, Mellemkjær, Lene, Malone, Kathleen E., Lynch, Charles F., Haile, Robert W., Concannon, Patrick, Reiner, Anne S., Duggan, David J., Schiermeyer, Katherine, Bernstein, Jonine L., Figueiredo, Jane C. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Netherlands
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709075/ |
Similar Items
-
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
by: Langballe, Rikke, et al.
Published: (2016) -
Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study
by: Sisti, Julia S., et al.
Published: (2015) -
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study
by: Teraoka, Sharon N, et al.
Published: (2011) -
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population
by: Anne S. Reiner, et al.
Published: (2017-07-01) -
Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer
by: Brooks, Jennifer D., et al.
Published: (2016)